Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC
Recruiting · NCT06868732 · Registry updated 2026-03-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC | Advanced Non-small Cell Lung Cancer | Recruiting | Phase 1 | 2026-03-30 | NCT06868732 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 17 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 113 |